MLN2480
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18945538
| Cas No. |
1096708-71-2 |
|---|---|
| Purity |
≥98% |
| Formula |
C17H12Cl2F3N7O2S |
| Formula Wt. |
506.30 |
| IUPAC Name |
2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
http://clinicaltrials.gov/show/NCT01425008
